izpis_h1_title_alt

Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals : evaluation of their impact on skin barrier function
ID Vitek, Mercedes (Author), ID Gosenca Matjaž, Mirjam (Author)

.pdfPDF - Presentation file, Download (1,38 MB)
MD5: BDED1679788AC05F34BC6E871E725FC4
URLURL - Source URL, Visit https://acta.pharmaceutica.farmaceut.org/wp-content/uploads/2024/05/30124.pdf This link opens in a new window

Abstract
The principal function of skin is to form an effective barrier between the human body and its environment. Impaired barrier function represents a precondition for development of skin diseases such as atopic dermatitis (AD), which is the most common inflammatory skin disease characterized by skin barrier dysfunction. AD significantly affects patients' quality of life, thus, there is a growing interest in development of novel delivery systems that would improve therapeutic outcomes. Herein, eight novel lyotropic liquid crystals (LCCs) were investigated for the first time in a double-blind, interventional, before-after, single group trial with healthy adult subjects and twice-daily application regimen. LCCs consisted of constituents with skin regenerative properties and exhibited lamellar microstructure, especially suitable for dermal application. The short- and long-term effects of LCCs on TEWL, SC hydration, erythema index, melanin index, and tolerability were determined and compared with baseline. LCCs with the highest oil content and lecithin/Tween 80 mixture stood out by providing a remarkable 2-fold reduction in TEWL values and showing the most distinctive decrease in skin erythema levels in both the short-and long-term exposure. Therefore, they exhibit great potential for clinical use as novel delivery systems for AD treatment, capable of repairing skin barrier function.

Language:English
Keywords:lamellar liquid crystals, atopic dermatitis, transepidermal water loss, stratum corneum hydration, erythema index, melanin index
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 301-313
Numbering:Vol. 74, no. 2
PID:20.500.12556/RUL-158261 This link opens in a new window
UDC:616.5-002
ISSN on article:1846-9558
DOI:10.2478/acph-2024-0014 This link opens in a new window
COBISS.SI-ID:180928771 This link opens in a new window
Publication date in RUL:31.05.2024
Views:377
Downloads:91
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Acta pharmaceutica
Shortened title:Acta pharm.
Publisher:Croatian Pharmaceutical Society
ISSN:1846-9558
COBISS.SI-ID:3817585 This link opens in a new window

Licences

License:CC BY-ND 4.0, Creative Commons Attribution-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nd/4.0/
Description:Under the NoDerivatives Creative Commons license one can take a work released under this license and re-distribute it, but it cannot be shared with others in adapted form, and credit must be provided to the author.

Secondary language

Language:Slovenian
Keywords:dermatitis, nevrodermitis, lamelarni tekoči kristali, atopijski dermatitis, transepidermalna izguba vode, hidracija stratum corneuma, eritemski indeks, melaninski indeks

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back